Trugenomix Health, Inc.
Blood test (PTS-ID) that uses genomic biomarkers to objectively diagnose post-traumatic stress disorder (PTSD)
- Sector
- Medtech
- Headquarters
- Rockville, MD
- Founded
- 2017
- Latest Form D
- $250K, Aug 2025
- Total capital
- $4.2M
- Federal grants
- $1.3M
- 2 awards · 2021–2022
- Rank in peer group#56 of 79
- Private capital raised
- $2.9M
- 6 Form D · last Aug 2025
- 14 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$250K
- Private capital raisedForm D · SEC · 5th filing$1M
- Private capital raisedForm D · SEC · 4th filing$1M
- Federal grantDefense · Phase II · Non-Self Reporting Screening Tool for PTSD$1.2M
- Federal grantDefense · Phase I · Proposal Phase 1$50K
- Private capital raisedForm D · SEC · 3rd filing$100K
- Private capital raisedForm D · SEC · 2nd filing$500K
- Private capital raisedForm D · SEC · 1st filing$75K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Anne Charles NaclerioResearcherDirectorLinked by $1.3M in grants as PI
- Charles CathlinExecutive Officer, DirectorNamed in SEC Form D filings
- Dr. Pardis Charles SabettiDirectorNamed in SEC Form D filings
- H. Charles CathlinExecutive Officer, DirectorNamed in SEC Form D filings
- Hubert Charles Cathlin, Jr.Executive Officer, DirectorNamed in SEC Form D filings
- Tshaka Charles CunninghamDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingGenetic Biomarkers for Identification of PTSD and Major DepressionUSPTOApplication 19243989
- PendingA Novel Biomarker For The Identification Of PtsdUSPTOApplication PCTUS2025013880
- PendingBiomarker for the Identification of PTSDUSPTOApplication 63626770
Show all 5 patent records
- Genetic Biomarkers for Identification of PTSD and Major DepressionJan 8, 2026 · Application 19243989Pending
- A Novel Biomarker For The Identification Of PtsdApplication PCTUS2025013880Pending
- Biomarker for the Identification of PTSDApplication 63626770Pending
- Genetic Biomarkers For Identification Of Ptsd And Major DepressionApplication PCTUS2023085806Pending
- Genetic Biomarkers for PTSD and Major DepressionApplication 63434605Pending
Related companies, and why
- CARDIO DIAGNOSTICS, LLCSimilar federal contract value in Medtech · null in contracts
- FITOTO TECHNOLOGIES INC.Similar federal contract value in Medtech · null in contracts
- Alio, Inc.Similar federal contract value in Medtech · null in contracts
- WYNNVISION, LLCSimilar federal contract value in Medtech · null in contracts
- UNPLUGS HEARING, INC.Similar federal contract value in Medtech · null in contracts
- ENTRATYMPANIC, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .